Site 540: Penyakit Infeksi Sulianti Saroso Hospital

Jakarta, DKI Jakarta, Indonesia
Specialized hospital in North Jakarta
Jl. Sunter Permai Raya No.2, RW.12, Papanggo, Kec. Tj. Priok, Kota Jkt Utara, Daerah Khusus Ibukota Jakarta 14340

About Site 540: Penyakit Infeksi Sulianti Saroso Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Site 540: Penyakit Infeksi Sulianti Saroso Hospital


During the past decade, Site 540: Penyakit Infeksi Sulianti Saroso Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
SUBLIVAC FIX Birch Phase III Short-term Efficacy
2014-09-01
2015-11-01
Completed
406
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
2015-08-01
2017-03-01
Completed
545
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
2015-09-01
2017-04-04
Completed
572
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
2016-02-16
2017-12-18
Completed
443
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
2017-09-18
2019-09-23
Completed
390
Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
2020-02-11
2022-06-22
Completed
206

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Site 540: Penyakit Infeksi Sulianti Saroso Hospital


According to Clinical.Site data, the most researched conditions in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" are "HIV" (1 trials) and "Infectious Disease" (1 trials). Many other conditions were trialed in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Site 540: Penyakit Infeksi Sulianti Saroso Hospital


Clinical Trials Genders at Site 540: Penyakit Infeksi Sulianti Saroso Hospital


The vast majority of trials in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" are 2 trials for "All" genders.

Clinical Trials Status at Site 540: Penyakit Infeksi Sulianti Saroso Hospital


Currently, there are NaN active trials in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Site 540: Penyakit Infeksi Sulianti Saroso Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Site 540: Penyakit Infeksi Sulianti Saroso Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status